Receptor mediated delivery of daunomycin using immunoliposomes: Pharmacokinetics and tissue distribution in the rat

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 3, 1997, Pages 1541-1546

  Huwyler, Jörg ^a,b   Yang, Jing ^a   Pardridge, William M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DAUNORUBICIN; DRUG RECEPTOR; IMMUNOGLOBULIN G2A; IMMUNOLIPOSOME; MACROGOL; MONOCLONAL ANTIBODY; TRANSFERRIN RECEPTOR;

ANIMAL CELL; AREA UNDER THE CURVE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; DRUG TISSUE LEVEL; DRUG UPTAKE; ENDOCYTOSIS; FLUORESCENCE; INTRAVENOUS DRUG ADMINISTRATION; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIBODIES, MONOCLONAL; DAUNORUBICIN; DRUG CARRIERS; GLIOMA; LIPOSOMES; MALE; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TRANSFERRIN; TISSUE DISTRIBUTION;

EID: 0030987679     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. AKAIKE, H.: Posterior probabilities for choosing a regression model. Ann. Inst. Stat. Math. A30: 9-14, 1978.
2. ALLEN, T. M.: Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends Pharmacol. Sci. 15: 215-220, 1994.
3. ALLEN, T. M., AHMAD, I., DEMENEZES, D. AND MOASE, E. H.: Immunoliposome-mediated targeting of anti-cancer drugs in vivo. Biochem. Soc. Transact. 23: 1073-1079, 1995a.
4. ALLEN, T. M., BHANDEIS, E., HANSEN, C. B., KAO, G. Y. AND ZALIPSKY, S.: A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. Biochim. Biophys. Acta 1237: 99-108, 1995b.
5. DERKSEN, J. T., MORSELT, H. W. AND SCHERPHOF, G. L.: Uptake and processing of immunoglobulin-coated liposomes by subpopulations of rat liver macrophages. Biochim. Biophys. Acta 971: 127-136, 1988.
6. EMANUEL, N., KEDAR, E., BOLOTIN, E. M., SMORODINSKY, N. I. AND BARENHOLZ, Y.: Preparation and characterization of doxorubicin-loaded sterically stabilized immunoliposomes. Pharm. Res. 13: 352-359, 1996.
7. FRANK, M. M.: The reticuloendothelial system and bloodstream clearance. J. Lab. Clin. Med. 122: 487-488, 1993.
8. GREGORIADIS, G., SENIOR, J., WOLFF, B. AND KIRBY, C.: Targeting of liposomes to accessible cells in vivo. Ann. N.Y. Acad. Sci. 446: 319-340, 1985.
9. HANSEN, C. B., KAO, G. Y., MOASE, E. H., ZALIPSKY, S. AND ALLEN, T. M.: Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. Biochim. Biophys. Acta 1239: 133-144, 1995
10. HUWYLER, J., WU, D. AND PARDRIDGE, W. M.: Brain drug delivery of small molecules using immunoliposomes. Proc. Natl. Acad. Sci. U.S.A. 93: 14164-14169, 1996.
11. JEFFERIES, W. A., BRANDON, M. R., HUNT, S. V., WILLIAMS, A. F., GATTER, K. C. AND MASON, D. Y.: Transferrin receptor on endothelium of brain capillaries. Nature 312: 162-163, 1984.
12. JEFFERIES, W. A., BRANDON, M. R., WILLIAMS, A. F. AND HUNT, S. V.: Analysis of lymphopoietic stem cells with a monoclonal antibody to the rat transferrin receptor. Immunology 54: 333-341, 1985.
13. JULIANO, R. L. AND STAMP, D.: Pharmacokinetics of liposome-encapsulated antitumor drugs. Studies with vinblastine, actinomycin D, cytosine arabinoside, and daunomycin. Bioch. Pharmacol. 27: 21-27, 1978.
14. KIRCHNER, E., HARTL, A., GUTTNER, J., FRITSCH, S. AND HOFFMANN, H.: Comparative studies on cardiotoxicity of some anthracycline antitumor antibiotics. Arch. Toxicol. Suppl. 4: 399-401, 1980.
15. KLIBAKOV, A. L., MARUYAMA, K., BECKERLEG, A. M., TORCHILIN, V. P. AND HUANG, L.: Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim. Biophys. Acta 1062: 142-148, 1991.
16. LASIC, D. D.: Doxorubicin in sterically stabilized liposomes. Nature 380: 561-562, 1996.
17. LASIC, D. D., CEH, B., STUART, M., GUO, L., FREDERIK, P. M. AND BARENHOLZ, Y.: Transmembrane gradient driven phase transitions within vesicles - lessons for drug delivery. Biochim. Biophys. Acta 1239: 145-156, 1995.
18. LASIC, D. D. AND PAPAHADJOPOULOS, D.: Liposomes revisited. Science 267: 1275-1276, 1995.
19. MARUYAMA, K., TAKIZAWA, T., YUDA, T., KENNEL, S. J., HUANG, L. AND IWATSURU, M.: Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies. Biochim. Biophys. Acta 1234: 74-80, 1995.
20. MORI, A., KLIBANOV, A. L., TORCHILIN, V. P. AND HUANG, L.: Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. FEBS Lett. 284: 263-266, 1991.
21. NAKANO, S., MATSUKADO, K. AND BLACK, K. L.: Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. Cancer Res. 56: 4027-4031, 1996.
22. PAPAHADJOPOULOS, D., ALLEN, T. M., GABIZON, A., MAYHEW, E., MATTHAY, K., HUANG, S. K., LEE, K. D., WOODLE, M. C., LASIC, D. D., REDEMANN, C. AND MARTIN, F. J.: Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. U.S.A. 88: 11460-11464, 1991.
23. PARDRIDGE, W. M.: Vector-mediated peptide drug delivery to the brain. Adv. Drug Delivery Rev. 15: 109-146, 1995.
24. PARDRIDGE, W. M., BOADO, R. J. AND KANG, Y. S.: Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo. Proc. Natl. Acad. Sci. U.S.A. 92: 5592-5596, 1995a.
25. PARDRIDGE, W. M., BUCIAK, J. L. AND FRIDEN, P. M.: Selective transport of an antitransferrin receptor antibody through the blood-brain barrier. J. Pharmacol. Exp. Ther. 259: 66-70, 1991.
26. PARDRIDGE, W. M., KANG, Y. S., YANG, J. AND BUCIAK, J. L.: Enhanced cellular uptake and in vivo biodistribution of a monoclonal antibody following cationization. J. Pharm. Sci. 84: 943-948, 1995b.
27. ROSENECKER, J., ZHANG, W., HONG, K., LAUSIER, J., GEPPETTI, P., YOSHIHARA, S., PAPAHADJOPOULOS, D. AND NADEL, J. A.: Increased liposome extravasion in selected tissues: Effect of substance P. Proc. Natl. Acad. Sci. U.S.A. 93: 7236-7241, 1996.
28. SHAHINIAN, S. AND SILVIUS, J. R.: A novel strategy affords high-yield coupling of antibody Fab' fragments to liposomes. Biochim. Biophys. Acta 1239: 157-167, 1995.
29. 125I]transferrin through the rat blood-brain barrier. Brain Res. 683: 164-171, 1995.
30. TORCHILIN, V. P.: Immunoliposomes and PEGylated immunoliposomes: Possible use for targeted delivery of imaging agents. Immunomethods 4:244-258, 1994.
31. WALUS, L. R., PARDRIDGE, W. M., STARZYK, R. M. AND FRIDEN, P. M.: Enhanced uptake of rsCD4 across the rodent and primate blood-brain barrier after conjugation to anti-transferrin receptor antibodies. J. Pharmacol. Exp. Ther. 277: 1067-1075, 1996.
32. YUAN, F., LEUNIG, M., HUANG, S. K., BERK, D. A., PAPAHADJOPOULOS, D. AND JAIN, R. K.: Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res. 54: 3352-3356, 1994.